Ownership Action Alert: Davita Healthcare Partners Inc Stock Decline in 2016 Q2 Driven by Institutional Investors

November 28, 2016 - By Peter Erickson   ·   0 Comments

Ownership Action Alert: Davita Healthcare Partners Inc Stock Decline in  2016 Q2 Driven by Institutional Investors

Sentiment for Davita Healthcare Partners Inc (NYSE:DVA)

Davita Healthcare Partners Inc (NYSE:DVA) institutional sentiment increased to 1.16 in 2016 Q2. Its up 0.12, from 1.04 in 2016Q1. The ratio increased, as 204 hedge funds increased and started new equity positions, while 196 sold and reduced their holdings in Davita Healthcare Partners Inc. The hedge funds in our partner’s database now own: 171.18 million shares, down from 176.89 million shares in 2016Q1. Also, the number of hedge funds holding Davita Healthcare Partners Inc in their top 10 equity positions increased from 13 to 16 for an increase of 3. Sold All: 34 Reduced: 162 Increased: 153 New Position: 51.

DaVita Inc., formerly DaVita HealthCare Partners Inc., is a well-known provider of kidney care services. The company has a market cap of $12.50 billion. The Firm operates Kidney Care division and HealthCare Partners division. It has a 18.32 P/E ratio. The Company’s divisions include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.

The stock closed at $63.33 during the last session. It is down 15.23% since April 25, 2016 and is downtrending. It has underperformed by 21.25% the S&P500.

Analysts await Davita Inc (NYSE:DVA) to report earnings on February, 9. They expect $0.91 EPS, down 9.90% or $0.10 from last year’s $1.01 per share. DVA’s profit will be $179.61 million for 17.40 P/E if the $0.91 EPS becomes a reality. After $0.95 actual EPS reported by Davita Inc for the previous quarter, Wall Street now forecasts -4.21% negative EPS growth.

According to Zacks Investment Research, “DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks primarily in California, Nevada, New Mexico, Florida, Colorado and Washington. DaVita Inc., formerly known as DaVita HealthCare Partners Inc., is headquartered in Denver, Colorado.”

Consulta Ltd holds 9.8% of its portfolio in Davita Inc for 1.00 million shares. Swift Run Capital Management Llc owns 192,602 shares or 9.51% of their US portfolio. Moreover, Triple Frond Partners Llc has 8.9% invested in the company for 715,600 shares. The Switzerland-based Gvo Asset Management Ltd has invested 6.31% in the stock. Norman Fields Gottscho Capital Management Llc, a New York-based fund reported 83,772 shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 insider buys, and 3 selling transactions for $1.94 million net activity.

Davita Inc (NYSE:DVA) Ratings Coverage

Ratings analysis reveals 17% of DaVita’s analysts are positive. Out of 6 Wall Street analysts rating DaVita, 1 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”. The lowest target is $71 while the high is $83. The stock’s average target of $73.25 is 15.66% above today’s ($63.33) share price. DVA was included in 11 notes of analysts from August 6, 2015. Bernstein maintained Davita Inc (NYSE:DVA) rating on Wednesday, March 2. Bernstein has “Market Perform” rating and $71 price target. JP Morgan initiated Davita Inc (NYSE:DVA) on Wednesday, September 16 with “Neutral” rating. The firm has “Sector Perform” rating by RBC Capital Markets given on Thursday, August 6. Raymond James upgraded Davita Inc (NYSE:DVA) on Tuesday, September 20 to “Outperform” rating. On Tuesday, February 16 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. As per Tuesday, August 9, the company rating was maintained by JP Morgan. Citigroup initiated the shares of DVA in a report on Tuesday, September 6 with “Neutral” rating. The stock of Davita Inc (NYSE:DVA) has “Neutral” rating given on Tuesday, September 6 by Bank of America. RBC Capital Markets maintained Davita Inc (NYSE:DVA) rating on Wednesday, November 4. RBC Capital Markets has “Sector Perform” rating and $80 price target.

DVA Company Profile

DaVita Inc., formerly DaVita HealthCare Partners Inc., incorporated on April 4, 1994, is a well-known provider of kidney care services. The Firm operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s divisions include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company’s Kidney Care division is a well-known provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.

More important recent Davita Inc (NYSE:DVA) news were published by: Prnewswire.com which released: “DaVita Inc. 3rd Quarter 2016 Results” on November 02, 2016, also Prnewswire.com published article titled: “DaVita Clinical Research to Present 12 Abstracts at American Society of …”, Prnewswire.com published: “DaVita Announces Change for Medicaid Patients Seeking Affordable Care Act Plan …” on October 31, 2016. More interesting news about Davita Inc (NYSE:DVA) was released by: Investorplace.com and their article: “Why Brocade Communications Systems, Inc. (BRCD), Davita Inc (DVA) and …” with publication date: October 31, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Peter Erickson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>